Awarded
SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS: ERENUMAB (AIMOVIG), BACLOFENO (LIORESAL INTRATECAL), OCTEOTRIDO IM (SANDOSTATIN LAR), EVEROLIMUS INMUNOSUPRESOR (CERTICAN), RIBOCICLIB (KISQALI) Y LAPATINIB (TYVERB)
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- NOVARTIS FARMACEÚTICA, S.A
- Contract value
- €91,268
- Bids received
- 1
- Published
- 8 Jul 2026
- Awarded
- 20 Apr 2026
- Contract start
- 20 Apr 2026
- Contract end
- 8 May 2027estimated
- Region
- Madrid